NOS3 and hyperphosphatemia: The development of endothelial dysfunction in CKD is driven by several factors, including oxidative stress, advanced glycation end products, inflammation, low vitamin D levels, hyperphosphatemia, elevated fibroblast growth factor 23, reduced α-Klotho, and the accumulation of endothelial nitric oxide synthase (eNOS) inhibitors [9,10].